WebApr 6, 2024 · Gerard Michel. Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company’s lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy … WebDCTH Complete Delcath Systems Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
DCTH Split History
WebDelcath Systems (DCTH) has 2 splits in our DCTH split history database. The first split for DCTH took place on April 09, 2014. This was a 1 for 16 reverse split, meaning for each 16 shares of DCTH owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 62.5 share position following the split. WebDelcath Systems (DCTH) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. 25/02/2024 21:53:10 1-888-992 … gameclub free spin
Agenus Inc. (AGEN) Stock Forum & Discussion - Yahoo Finance
WebApr 6, 2024 · 3 equities research analysts have issued 12 month price objectives for Delcath Systems' shares. Their DCTH share price forecasts range from $14.00 to $19.00. On … WebDec 16, 2024 · Delcath Systems to Participate at the BTIG MedTech, Digital Health, Life Sciences & Diagnostic Tools Conference on February 14 to 16 • PR Newswire (US) • 01/30/2024 01:30:00 PM. Current Report Filing (8-k) … WebJun 22, 2024 · Also, dont forget.. this is not an OTC stock. This is on NASDAQ. Any newbie investor who ever wanted to try a big board stock but didnt have the money to spend $45 per share... DCTH may be a good opportunity; but ONLY after you research it and do NOT invest more than you can afford to lose. black dress with black and white shoes